Multiplex rapid test simultaneously detecting COVID-19, influenza A, and influenza B from a single specimen. FDA cleared with results available in 5 minutes.
Manufactured by
San Diego, CA, United States
Founded by lateral-flow scientists in 2009, Advin Biotech, Inc. is an FDA registered purveyor of lateral-flow rapid diagnostics, specializing in the innovative design, structured development, and efficient manufacture of premium quality, competitively priced drugs of abuse test kits for distribution in the U.S. and internationally. With vast experience in the field of toxicology, we offer a complete line of one-step, FDA approved drug tests for medical, workplace, laboratory, and criminal justice organizations. We strive to provide the most accurate, reliable and innovative products for point of care diagnostics. We aim to augment our existing FDA cleared test menu with first-to-market, “organically grown” assays targeted to fill the gaps in the diverse toxicology market. Ultimately, we hope to collaborate with medical and forensic experts around the world to provide affordable, accurate, and actionable tests that fill unmet needs. The toxicology and drug testing market is constantly evolving, and we strive to constantly stay on top of market trends and technology to provide the most innovative, highest quality, and highest value drug testing products for our customers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SureScreen Diagnostics Limited
United Kingdom · 5 relevant products
Reagen Inc.
United States · 2 relevant products
CorDx
United States · 1 relevant product
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 2 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
Xiamen Biotime Biotechnology Co., Ltd.
China · 2 relevant products
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 1 relevant product
ProGnosis Biotech S.A.
Greece · 2 relevant products
Famwell
United States · 3 relevant products
GenSure Biotech Inc.
China · 1 relevant product
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 118 closest product alternatives
SureScreen Diagnostics Limited · United Kingdom
A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
Reagen Inc. · United States
Multiplex rapid test kit for simultaneous detection and differentiation of COVID-19, Influenza A, Influenza B, and RSV in a single test strip. Provides results in under 10 minutes for respiratory pathogen screening.
CorDx · United States
Multiplex rapid immunoassay for simultaneous detection of Influenza A, Influenza B, and SARS-CoV-2 from respiratory specimens. Delivers results in approximately 15 minutes, enabling quick clinical decision-making in point-of-care and laboratory settings. Single-use test cartridge with integrated sample processing and built-in quality controls.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specificity for viral antigen identification.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
Xiamen Biotime Biotechnology Co., Ltd. · China
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2 antigen and influenza A/B viruses.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
Rapid molecular detection kit for simultaneous identification of SARS-CoV-2, influenza A, and influenza B viruses. Utilizes isothermal amplification technology for quick diagnostic results.
ProGnosis Biotech S.A. · Greece
Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
Famwell · United States
Combined rapid diagnostic test for simultaneous detection of both Influenza A and B antigens from a single nasopharyngeal swab specimen. FDA-cleared point-of-care format delivering results within 10 minutes.
GenSure Biotech Inc. · China
Rapid antigen detection test kit for simultaneous identification of Influenza A and B viruses from respiratory specimens. Delivers results within minutes using immunochromatographic technology, enabling point-of-care diagnosis in clinical and home settings. NMPA-approved for accurate respiratory pathogen screening.
BioTeke Corporation(wuxi) Co.,Ltd · China
Multipathogen antigen detection test for simultaneous identification of COVID-19, Influenza A and B, and RSV from nasal swab specimens. Designed for professional laboratory use.
MedLevensohn · Brazil
A rapid diagnostic combo test for simultaneous detection of COVID-19 and Influenza H1N1 antigens.
106 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products